STEPHEN JOHN VALAZZA
Pharmacy in Matawan, NJ
License number
Pennsylvania RP038019T
Category
Pharmacy
Type
Pharmacist
Address
Address
2
Matawan, NJ 07747
Pennsylvania
Pennsylvania
Personal information
See more information about STEPHEN JOHN VALAZZA at radaris.comName
Address
Phone
10 Porsche Dr, Matawan, NJ 07747
Matawan, NJ
10 Porsche Dr, Matawan, NJ 07747
Professional information
See more information about STEPHEN JOHN VALAZZA at trustoria.com
Organic Compounds
Organic Compounds
US Patent:
6432447, Aug 13, 2002
Filed:
May 17, 2001
Appl. No.:
09/859861
Inventors:
Oskar Michael Kalb - Loerrach, DE
Stephen John Valazza - Matawan NJ
Stephen John Valazza - Matawan NJ
Assignee:
Novartis AG - Basel
International Classification:
A61K 922
US Classification:
424468, 424465, 424474, 424464, 424480
Abstract:
An oral dosage form comprising fluvastatin and HPMC, which oral dosage form is color-stable upon prolonged periods of storage.
Galenical Formulations Of Organic Compounds
Galenical Formulations Of Organic Compounds
US Patent:
8613949, Dec 24, 2013
Filed:
Sep 22, 2009
Appl. No.:
13/063955
Inventors:
Stephen Valazza - Matawan NJ, US
Robert F Wagner - Hillsborough NJ, US
Sudha Vippagunta - Morris Plains NJ, US
Robert F Wagner - Hillsborough NJ, US
Sudha Vippagunta - Morris Plains NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 9/28, A61K 9/20
US Classification:
424474, 514616
Abstract:
The present invention relates to a pharmaceutical oral fixed dose combination comprising.
Pharmaceutical Compositions Comprising Fluvastatin
Pharmaceutical Compositions Comprising Fluvastatin
US Patent:
8303987, Nov 6, 2012
Filed:
Jul 13, 2010
Appl. No.:
12/835195
Inventors:
Oskar Kalb - Lorrach, DE
Stephen Valazza - Matawan NJ, US
Stephen Valazza - Matawan NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 9/26, A61K 9/14, A61K 9/20, A61K 9/22, A61K 9/50, A61K 31/405
US Classification:
424469, 424489, 424464, 424468, 424499, 514415
Abstract:
Pharmaceutical compositions comprising fluvastatin, HPMC and optionally other pharmaceutical excipients which are colour-stable upon prolonged periods of storage.
Pharmaceutical Compositions Comprising Fluvastatin
Pharmaceutical Compositions Comprising Fluvastatin
US Patent:
2006012, Jun 15, 2006
Filed:
Feb 3, 2006
Appl. No.:
11/347040
Inventors:
Oskar Kalb - Lorrach, DE
Stephen Valazza - Matawan NJ, US
Stephen Valazza - Matawan NJ, US
International Classification:
A61K 9/20, A61K 9/14, A61K 31/225
US Classification:
424464000, 514548000, 424489000
Abstract:
Pharmaceutical compositions comprising fluvastatin, HPMC and optionally other pharmaceutical excipients which are colour-stable upon prolonged periods of storage.
Pharmaceutical Compositions Comprising Fluvastatin
Pharmaceutical Compositions Comprising Fluvastatin
US Patent:
2003017, Sep 11, 2003
Filed:
Oct 15, 2002
Appl. No.:
10/257614
Inventors:
Oskar Kalb - Lorrach, DE
Stephen Valazza - Matawan NJ, US
Stephen Valazza - Matawan NJ, US
International Classification:
A61K031/405, A61K009/20
US Classification:
514/419000, 424/465000
Abstract:
Pharmaceutical compositions comprising fluvastatin, HPMC and optionally other pharmaceutical excipients which are colour-stable upon prolonged periods of storage.
Organic Compounds
Organic Compounds
US Patent:
2012028, Nov 15, 2012
Filed:
Jul 19, 2012
Appl. No.:
13/553387
Inventors:
Michael Ambühl - Bridgewater NJ, US
Jutta Beyer - Acton MA, US
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
Jutta Beyer - Acton MA, US
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
International Classification:
A61K 9/00, A61K 9/14, A61K 31/137, A61P 37/06, A61P 29/00, A61P 37/00, A61P 25/28, A61K 47/02, A61K 47/38, A61K 47/34, C07C 215/28, A61K 9/30, C07C 225/16, A61K 9/48, A61K 9/16
US Classification:
424451, 424400, 424490, 514653, 514770, 514781, 564360, 424475
Abstract:
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator.
Organic Compounds
Organic Compounds
US Patent:
2010004, Feb 18, 2010
Filed:
Sep 25, 2007
Appl. No.:
12/442781
Inventors:
Michael Ambuhl - Rheinfelden, CH
Jutta Beyer - Basel, CH
Begona Carreno-Gomez - Basel, CH
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
Jutta Beyer - Basel, CH
Begona Carreno-Gomez - Basel, CH
Colleen Ruegger - Morris Plains NJ, US
Stephen Valazza - Matawan NJ, US
International Classification:
A61K 9/50, A61K 47/04, A61K 9/32, A61K 9/36, A61K 9/48, A61K 31/135, A61K 9/64, A61P 37/00, A61P 29/00, A61P 41/00
US Classification:
424456, 514769, 514770, 424497, 424482, 424494, 424480, 424463, 514653
Abstract:
The present invention provides various pharmaceutical compositions comprising an S1P receptor modulator, e.g. an S1P receptor agonist. In one aspect, there is provided a pharmaceutical composition having a coating. In other aspects, rapid disintegrating compositions are provided. In a further aspect, a pharmaceutical composition which is free of sugar alcohols is provided. In another aspect, the invention provides a pharmaceutical composition comprising a coating comprising an S1P receptor modulator.
Organic Compounds
Organic Compounds
US Patent:
6242003, Jun 5, 2001
Filed:
Apr 13, 2000
Appl. No.:
9/549222
Inventors:
Oskar Michael Kalb - Loerrach, DE
Stephen John Valazza - Matawan NJ
Stephen John Valazza - Matawan NJ
Assignee:
Novartis AG - Basel
International Classification:
A61K 922, A61K 926, A61K 914, A61K 916, A61K 936
US Classification:
424468
Abstract:
An oral dosage form comprising fluvastatin and HPMC, which oral dosage form is color-stable upon prolonged periods of storage.